Nippon India Pharma Fund - Direct - Growth

Equity Schemes by Nippon Life India Asset Management Limited

3Y Returns (CAGR)
17.00%
Expense Ratio
0.93%

as of 01/06/2026

AUM
₹2,251.45 Cr

Qtr End: Jun 26

NAV
₹604.31

as of 16/10/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M-5.13%-19.01%11.53%
6M7.07%14.64%12.04%
1Y4.89%4.89%12.28%
3Y60.17%17.00%13.14%
5Y86.40%13.26%13.04%
Scheme Details
Launch Date
10/05/2004
Fund Age
22.4 years
Minimum Investment
₹5,000
Fund House
Nippon India Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions